Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Middle East Healthcare CoSAU:4009 +0.87%75 Return-on-Tangible-Asset is 2.61% as of Jun. 2026, which is 42% below its 10-year median of 4.49. GuruFocus rates SAU:4009 with a GF Score™ of 75/100 and a GF Value™ of ﷼76.95 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Middle East Healthcare Co ranks better than 50.66% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Middle East Healthcare Co's annualizedNet Income for the quarter that ended in Jun. 2026 was ﷼137 Mil. Middle East Healthcare Co's average total tangible assets for the quarter that ended in Jun. 2026 was ﷼5,257 Mil. Therefore, Middle East Healthcare Co's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 2.61%.
The historical rank and industry rank for Middle East Healthcare Co's Return-on-Tangible-Asset or its related term are showing as below:
SAU:4009'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.36 Med: 4.49 Max: 16.53
Current: 2.61
During the past 11 years, Middle East Healthcare Co's highest Return-on-Tangible-Asset was 16.53%. The lowest was 0.36%. And the median was 4.49%.
SAU:4009's Return-on-Tangible-Asset is ranked better than 50.66% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs SAU:4009: 2.61
Middle East Healthcare Co (SAU:4009) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Middle East Healthcare Co Return-on-Tangible-Asset Related Terms
Middle East Healthcare Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Middle East Healthcare Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Healthcare Co Return-on-Tangible-Asset Chart
SAU:4009 vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Middle East Healthcare Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Healthcare Co Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Middle East Healthcare Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.61% mean?
Middle East Healthcare Co (SAU:4009) has a Return-on-Tangible-Asset of 2.61% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Middle East Healthcare Co and its competitors. This is 42% below median its historical median of 4.49. Over the past decade, Middle East Healthcare Co's Return-on-Tangible-Asset has ranged from 0.36 to 16.53. According to the industry distribution chart, Middle East Healthcare Co ranks #337 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 49.3%.
Is Middle East Healthcare Co's Return-on-Tangible-Asset too high?
Middle East Healthcare Co's current Return-on-Tangible-Asset of 2.61% is 42% below median its 10-year median of 4.49. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 16.53. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Middle East Healthcare Co's value of 2.61% is 7.4% above this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #337 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Middle East Healthcare Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #337 out of 683 companies for Return-on-Tangible-Asset. This puts Middle East Healthcare Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.43. Middle East Healthcare Co's value of 2.61% is 7.4% above this benchmark. Historically, Middle East Healthcare Co's own Return-on-Tangible-Asset has ranged from 0.36 to 16.53 over the past decade. While the company's 10-year median is 4.49 vs. the industry median of 2.43, Middle East Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current Return-on-Tangible-Asset of 2.61% is 7.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current Return-on-Tangible-Asset is 2.61%, which is 42% below median its own 10-year median of 4.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼76.95, compared to a current price of ﷼32.38 — trading 57.9% below its estimated fair value. The current Return-on-Tangible-Asset is 2.61%, which is 42% below median its 10-year median of 4.49 and 7.4% above the Healthcare Providers & Services industry median of 2.43. Middle East Healthcare Co's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current Return-on-Tangible-Asset is 2.61% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?
Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued.
The current stock price of ﷼32.38 is trading 57.9% below its estimated GF Value™ of ﷼76.95.
GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4009:
Return-on-Tangible-Asset: 2.61% (42% below median its 10-year median of 4.49)
GF Value™: ﷼76.95 vs. price of ﷼32.38 (57.9% below fair value)
Industry Position: 7.4% above the Healthcare Providers & Services median (#337 of 683)
No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
75GF Score
Get the complete analysis for SAU:4009
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4009 has been successfully added to your 
